The Apple Watch and Hypertension: What Wearable Tech Can (and Can’t) Do

Wearable technology is moving fast — and Apple’s new hypertension detection feature has sparked interest. Can a smartwatch really replace your blood pressure cuff? The short answer: not yet. But it’s opening new possibilities in preventive health.

The new hypertension detection feature in the Apple Watch uses cuffless technology, likely involving photoplethysmography (PPG) and pulse transit time (PTT), to estimate blood pressure trends over time. This approach allows the device to monitor cardiovascular signals and flag users who may be at risk of high blood pressure, all without a traditional cuff.

While the feature reflects exciting progress in wearable technology, it is important to recognize that it has not yet been clinically validated for the accurate measurement or diagnosis of hypertension. Current peer-reviewed studies have shown that smartwatch-based cuffless methods often produce variable results, with mean errors ranging from 5 to 13 mmHg, depending on user characteristics and movement. As a result, major clinical bodies and regulators do not currently recommend these devices for medical decision-making.

That said, the technology’s potential lies in screening and engagement rather than diagnosis. The feature may not replace an upper-arm cuff for precise readings, but it opens new possibilities for passive, long-term cardiovascular monitoring, something that was not possible at this scale even a few years ago.

For individuals at risk of developing high blood pressure, due to factors like age, stress, lifestyle, or family history, this feature could serve as an early engagement tool. By providing trend-based notifications, the Apple Watch may prompt users to seek formal testing, adopt healthier habits, or monitor their lifestyle more closely. The ability to observe fluctuations in blood pressure alongside other metrics like heart rate, sleep, and activity levels can help users better understand how their daily behaviours influence cardiovascular health.

While the Apple Watch is not a diagnostic tool, its wellness-oriented design can play a supportive role in hypertension prevention and self-management. In rehabilitation settings and chronic disease prevention, studies have shown that wearables like the Apple Watch can boost physical activity levels and support behavioural change, especially when used in combination with health coaching or app-based interventions.

From a consumer perspective, this feature may well be a strong incentive to purchase an Apple Watch, particularly for those already health-conscious or looking for tools to support better lifestyle choices. However, it’s equally important for users to understand its limits: the feature is not meant to guide treatment or replace validated medical devices. For diagnosis and monitoring of high blood pressure, upper-arm cuff monitors remain the gold standard.

Apple’s trajectory clearly signals a move toward making the Watch a more comprehensive health companion, and the hypertension detection feature is a step in that direction. Looking ahead, we can expect Apple to focus on improving the clinical accuracy of its existing sensors, particularly for blood pressure, and to pursue validation studies and regulatory approvals that could eventually allow the Watch to be used in formal healthcare settings.

There is also room for greater integration of multiple health signals, such as combining sleep data, heart rate variability, ECG, activity levels, and estimated blood pressure, to provide more personalized and actionable health insights. As machine learning and AI capabilities evolve, Apple could potentially use the Watch to detect early warning signs of disease, predict health risks, or support preventive care strategies tailored to individual users.

Another critical area will be ensuring that these technologies work reliably across different skin tones, age groups, and comorbidities, while also addressing privacy, data interoperability, and usability in clinical workflows.

In summary, while the Apple Watch’s hypertension detection feature is not a replacement for clinical tools, it represents a meaningful advance in consumer health technology. It encourages greater engagement, promotes awareness, and supports preventive behaviours, all of which are essential components of long-term cardiovascular health. With continued development and rigorous validation, we may see future versions move closer to integration into routine healthcare.

Spatz ES, Ginsburg GS, Rumsfeld JS, Turakhia MP. Wearable Digital Health Technologies for Monitoring in Cardiovascular Medicine. N Engl J Med. 2024;390(4):346–356. doi:10.1056/NEJMra2301903

Mukkamala R, Shroff SG, Kyriakoulis KG, Avolio AP, Stergiou GS. Cuffless Blood Pressure Measurement: Where Do We Actually Stand? Hypertension. 2025;82(6):957–970. doi:10.1161/HYPERTENSIONAHA.125.24822

Stergiou GS et al. Cuffless Blood Pressure Measuring Devices: Statement by the ESH Working Group. J Hypertens. 2022;40(8):1449–1460. doi:10.1097/HJH.0000000000003224

Liu ZD et al. Cuffless Blood Pressure Measurement Using Smartwatches: A Large-Scale Validation Study. IEEE J Biomed Health Inform. 2023;27(9):4216–4227. doi:10.1109/JBHI.2023.3278168

Han M et al. Feasibility and Measurement Stability of Smartwatch-Based Cuffless Blood Pressure Monitoring. Hypertens Res. 2023;46(4):922–931. doi:10.1038/s41440-023-01215-z

Yen HY, Huang WH. The Efficacy of Commercial Smartwatches With a Blood Pressure-Monitoring Feature: A Pilot RCT. J Nurs Scholarsh. 2022;54(3):324–331. doi:10.1111/jnu.12740

Tedeschi R et al. Wearable Technology in Rehabilitation: Assessing the Impact of the Apple Watch. J Sports Med Phys Fitness. 2025;S0022-4707.25.16874-6. doi:10.23736/S0022-4707.25.16874-6

Ginsburg GS, Picard RW, Friend SH. Key Issues as Wearable Digital Health Technologies Enter Clinical Care. N Engl J Med. 2024;390(12):1118–1127. doi:10.1056/NEJMra2307160